BioNTech SE (BNTX) Cash from Discontinued Operations (2019 - 2025)
BioNTech SE's (BNTX) quarterly Cash from Discontinued Operations came in at 912681309.82 in Q3 2025, up 230.08% year-on-year from 276506427.74 in Q3 2024, and up 450.36% quarter-over-quarter from 165832094.29 in Q2 2025.
BioNTech SE (BNTX) Cash from Discontinued Operations (2019 - 2025) Analysis & Trends
BioNTech SE has disclosed Cash from Discontinued Operations across 7 years of filings, most recently posting 912681309.82 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 912.68 Mn |
| Sep 30, 2025 | 912.68 Mn |
| Jun 30, 2025 | 165.83 Mn |
| Jun 30, 2025 | 165.83 Mn |
| Mar 31, 2025 | -821.21 Mn |
| Mar 31, 2025 | -821.21 Mn |
| Sep 30, 2024 | -701.65 Mn |
| Sep 30, 2024 | -701.65 Mn |
| Jun 30, 2024 | 1.75 Bn |
| Jun 30, 2024 | 1.75 Bn |
| Mar 31, 2024 | -344.70 Mn |
| Mar 31, 2024 | -344.70 Mn |
| Sep 30, 2023 | 883.06 Mn |
| Sep 30, 2023 | 883.06 Mn |
| Jun 30, 2023 | 4.78 Bn |
| Jun 30, 2023 | 4.78 Bn |
| Mar 31, 2023 | -727.08 Mn |
| Mar 31, 2023 | -727.08 Mn |
| Sep 30, 2022 | 4.82 Bn |
| Sep 30, 2022 | 4.82 Bn |